Biotech China 2014

Proteomics: AstraZeneca

Total Score People Score Events Score
26 21 19
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Drug Development Track: New Drugs on the Horizon 1 Co-Chairpersons: Lori S. Friedman, Genentech, Inc., South San Francisco, CA, and Simon Bailey, Pfizer, Inc., San Diego, CA Dennis Huszar
January 31, 2011 Biomarkers Summit STREAM ONE | PRECLINICAL CANCER MODELS USED IN DRUG DISCOVERY AND TRANSLATIONAL ONCOLOGY Robert Wilkinson
THE APPLICATION OF INFORMATICS TO BIOMARKER DEVELOPMENT Hugh Salter
ISSUES IN STATISTICAL VALIDATION OF BIOMARKERS AS SURROGATE ENDPOINTS IN CLINICAL TRIALS Ziad Taib
May 4, 2010 Biomarker World Congress 2010 New Era with Targeted Drugs: New Development Approaches are Needed to Achieve Success Geert J.C.M. Kolvenbag
April 30, 2010 Drug Story Development of a Portfolio of Therapeutic Antibodies for Oncology Combining Xenomouse and Display Technologies David Blakey
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit 4 Case Study: Conducting Proof-of-Concept Studies in China Karen Atkin
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis New Biomarkers: Opportunities and Challenges Anastasia M. Khoury Christianson
August 24, 2009 Specialized Protein Expression Systems In vivo Encapsulation of Recombinant Proteins as Universal Production Platform Stefan R. Schmidt
Chairperson’s Remarks Stefan R. Schmidt
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Comparison of Whole-Cell, Label-Free Assays for GPCR Drug Discovery Matthew Peters
January 26, 2009 Translational Cancer Medicine VANDETANIB : Pretreatment Circulating VEGF Levels as A Predictive Biomarker of Efficacy in NSCLC Patients Treated with Vandetanib Anderson Ryan
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Session Chair :Track 1-10 James Jianguo Li
Small Molecule Inhibitors Targeting Mutation Driven Cancers :Track 2-4 (I) Jeannie Hou
October 20, 2008 Protein Expression Europe Comments by Session Chairperson Stefan R. Schmidt
Fusion-Proteins as Biopharmaceuticals: Applications and Challenges Stefan R. Schmidt
September 29, 2008 Genomic Biomarkers Personalized Healthcare – Where Are We Now? Ruth E. March
September 29, 2008 Metabolic Biomarkers Metabolomics/Proteomics: Tools for Biomarker Discovery within Safety Assessment Johan Lindberg
April 27, 2008 Phage Display of Antibodies and Peptides Development of a Portfolio of Therapeutic David Blakey
April 27, 2008 Phage Display of Antibodies and Peptides Development of a Portfolio of Therapeutic Antibodies for Oncology Combining Xenomouse and Display Technologies David Blakey
March 31, 2008 China 2008 Pharmaceutical R&D Summit Track II Embarking on a Long March for Early Drug Development in China James Cai
November 5, 2007 Second Annual Biomarkers Europe Nov (05-06) BIOMARKERS IN PERSONALIZED MEDICINE: Quantifying the Additional Benefits of Proteomics in Patient Selection (16:00-16:30) Chris Harbron
BIOMARKERS IN PERSONALIZED MEDICINE: Genome-Wide Pharmacogenetic Investigation of Adverse Events: A Case Study (13:15-13:45) Ruth E. March
BIOMARKERS IN PERSONALIZED MEDICINE (13:10-17:00) Ruth E. March, Chris Harbron
BIOMARKERS FOR SAFETY ASSESSMENT (14:00-15:45) Graham Betton
BIOMARKERS FOR SAFETY ASSESSMENT: Biomarkers of Nephrotoxicity in Toxicology and the Clinic (14:00-14:30) Graham Betton
September 27, 2007 Protein Expression Europe (Sep 27-28) Protein Localization (13:25-16:15) Stefan R. Schmidt
Protein Localization: Comments by Session Chairperson (13:25-13:30) Stefan R. Schmidt
Breakfast BuzZ Sessions (08:00-09:00) Niek Dekker
Breakfast BuzZ Session IV: Sampling Expression Space (08:00-09:00) Niek Dekker
Drug Discovery Applications (13:00-15:15) Niek Dekker
Drug Discovery Applications: Purified Membrane Protein Targets for Drug Discovery (13:45-14:15) Niek Dekker
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: PHARMACOGENETICS: Major Pharmacogenetics Studies Using a Combination of Genome-Wide Tagging SNPs and High Density SNP Genotyping in Candidate Genes (10:05-10:35) Neil Gibson
Third annual Genomic Biomarkers: PHARMACOGENETICS (08:30-11:30) Neil Gibson
Eight Annual Metabolic Biomarkers: METABOLIC BIOMARKER DISCOVERY (08:30-11:00) Stephen Furlong
Eight Annual Metabolic Biomarkers; METABOLIC BIOMARKER DISCOVERY: Urine and Plasma Biomarkers in Schizophrenia (09:05-09:35) Stephen Furlong
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.